Oncology is the branch of medicine that specializes in the diagnosis, treatment, and prevention of cancer. This field encompasses various treatment modalities, including chemotherapy, radiation therapy, and surgical oncology, to treat a wide range of cancers. Oncologists also focus on cancer prevention, providing holistic treatment plans for patients at different stages of their cancer journey.
At KCH Oncology, our dedicated team of Board-Certified Oncologists, skilled nurses, and clinical staff provides holistic, individualized care from diagnosis to survivorship. We emphasize clinical expertise and compassion, integrating cutting-edge treatments and research, including clinical trials, to enhance patient recovery. Our comprehensive approach supports patients and their families through the challenges of cancer, focusing on physical, emotional, and spiritual well-being while delivering culturally sensitive care.
Our Oncology department excels in providing cutting-edge cancer care, aligning with international standards and offering the latest treatments, including targeted therapies and immunotherapies. We emphasize personalized medicine, backed by advanced diagnostic technologies and genetic testing. Our active research and clinical trials access ensure patients receive the most innovative care. We adopt a multidisciplinary approach to treatment decisions, ensuring comprehensive care
When choosing our oncologists, we value clinical expertise and compassion equally. Our team, known for significant cancer research contributions and mastery in advanced treatments, is committed to enhancing patient outcomes and oncology progress. Their dedication to patient-focused care and ongoing education underscores their excellence in the field.
Medical Oncology focuses on diagnosing, treating, and managing cancer using systemic therapies such as chemotherapy, hormonal therapy, immunotherapy, and targeted therapy. Medical oncologists play a central role in the multidisciplinary care of cancer patients, coordinating treatment plans that may include various modalities based on the type, stage, and location of cancer, as well as the patient’s overall health and preferences.
Chemotherapy
Chemotherapy utilizes powerful drugs to target and kill cancer cells, often used as a primary treatment or adjunctively to shrink tumors before surgery or radiation. Treatment regimens are highly personalized, considering the cancer’s type and progression. Medical oncologists carefully balance the potential benefits against the side effects, providing supportive care to manage any adverse reactions. This approach aims to maximize the effectiveness of treatment while minimizing impact on the patient’s quality of life.
Hormonal Therapy
Hormonal therapy is used to treat cancers that are hormone receptor-positive, such as certain types of breast and prostate cancer, by blocking the body’s natural hormones or altering their effects on cancer cells. This treatment can slow or stop the growth of hormone-sensitive tumors. Medical oncologists determine eligibility through diagnostic testing, integrating hormonal therapy into the broader treatment plan to target specific pathways that fuel cancer growth, offering a strategic approach to control the disease.
Immunotherapy
Immunotherapy harnesses the power of the body’s immune system to fight cancer, offering a promising approach for various cancer types. This method can boost or change how the immune system works, making it more effective at detecting and destroying cancer cells. Medical oncologists evaluate the suitability of immunotherapy based on specific markers and the cancer’s characteristics, providing another tool in the treatment arsenal that can sometimes offer benefits where other therapies have not, improving outcomes and survival rates for patients.
Targeted Therapy
Targeted therapy focuses on specific genes, proteins, or the tissue environment that contributes to cancer growth and survival. These therapies block the growth and spread of cancer by interfering with specific molecular targets. Medical oncologists utilize diagnostic tests to identify actionable targets within cancer cells, selecting therapies that offer a more precise attack on cancer with potentially fewer side effects compared to traditional chemotherapy. This approach represents a shift towards personalized cancer care, tailoring treatments to individual patient profiles for improved efficacy.
Surgical Oncology is a critical branch of cancer care focusing on the surgical removal of tumors and surrounding tissues as a primary method to treat cancer. Surgical oncologists specialize in the diagnosis, staging, and surgical treatment of cancer, employing techniques ranging from traditional open surgeries to minimally invasive procedures, aiming to achieve the best possible outcomes while preserving function and reducing recovery time.
Tumor Resection
Tumor resection involves the surgical removal of cancerous tumors and, in some cases, nearby lymph nodes to assess the cancer’s spread. This procedure can be curative for many types of cancer when performed in the early stages. Surgical oncologists carefully plan resections to remove all or most of the tumor while sparing healthy tissue, utilizing advanced imaging techniques for precision. The goal is to achieve clear margins around the tumor, minimizing the risk of recurrence.
Minimally Invasive Surgery
Minimally invasive surgery, including laparoscopy and robotic-assisted techniques, offers patients the benefit of smaller incisions, less pain, and quicker recovery times compared to traditional open surgery. These techniques allow surgeons to operate with greater precision and flexibility. Surgical oncologists use minimally invasive procedures when appropriate, based on the tumor’s size, location, and type, enhancing patient outcomes and preserving quality of life by reducing hospital stays and facilitating a faster return to normal activities.
Sentinel Lymph Node Biopsy
Sentinel lymph node biopsy is a procedure used to determine if cancer has spread to the lymphatic system, particularly important in breast cancer and melanoma management. This technique identifies and removes the first lymph nodes to which cancer cells are likely to spread. Surgical oncologists perform this minimally invasive procedure to assess cancer stage without the need for extensive lymph node removal, reducing the risk of complications such as lymphedema and providing critical information for guiding further treatment decisions.
Cytoreductive Surgery and HIPEC
Cytoreductive surgery, combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC), is used primarily to treat cancers that spread within the abdominal cavity, such as ovarian and certain colorectal cancers. This approach involves the surgical removal of visible tumors followed by the direct application of heated chemotherapy drugs to the abdomen to kill any remaining cancer cells. Surgical oncologists specialize in this complex procedure, offering a potential cure or significant prolongation of life for patients with advanced abdominal cancers.
Reconstructive Surgery
Reconstructive surgery after cancer treatment aims to restore appearance and function affected by cancer surgery, such as breast reconstruction after mastectomy. Surgical oncologists work closely with plastic surgeons to plan and perform these procedures, often at the same time as tumor removal or as a separate operation. The focus is on improving the patient’s quality of life post-treatment, with techniques tailored to each patient’s needs and preferences, ensuring the best possible aesthetic and functional outcomes.
Radiation Oncology is a medical specialty that focuses on using ionizing radiation to treat cancer. Radiation oncologists develop and oversee radiation therapy plans to target cancer cells, aiming to cure or reduce the symptoms of cancer while minimizing exposure to surrounding healthy tissues. This discipline plays a pivotal role in a multidisciplinary approach to cancer care, often combining with surgery and medical oncology for comprehensive treatment.
External Beam Radiation Therapy (EBRT)
EBRT delivers high-energy rays directly to the tumor site from an external machine, sparing surrounding healthy tissue. Techniques like intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT) allow for precise targeting of tumors, enhancing the efficacy and reducing side effects. Radiation oncologists tailor the treatment plan based on tumor size, location, and type, often using EBRT as a primary treatment or adjunctively to shrink tumors before surgery or address residual cancer cells post-operatively.
Brachytherapy
Brachytherapy involves placing radioactive sources close to or inside the tumor, delivering a high radiation dose directly to cancer cells while protecting adjacent healthy tissues. Commonly used in prostate, cervical, and breast cancers, this technique allows for shorter treatment durations and reduced side effects compared to EBRT. Radiation oncologists assess the suitability for brachytherapy based on the cancer’s specifics, providing a personalized treatment that enhances precision and outcomes for patients.
Stereotactic Radiosurgery
SRS is a non-surgical radiation therapy used to treat small tumors in the brain and spine with high precision. Despite its name, SRS does not involve incisions, instead delivering concentrated doses of radiation to target tumors accurately, minimizing damage to surrounding brain tissue. Radiation oncologists utilize advanced imaging to guide treatment, making SRS an effective option for patients with inoperable tumors or those seeking an alternative to traditional brain surgery, offering significant tumor control with minimal recovery time.
Proton Therapy
Proton therapy is an advanced form of radiation treatment that uses protons instead of X-rays to treat cancer. Its main advantage lies in the protons’ ability to deposit their maximum energy directly in the tumor with minimal exit dose, reducing radiation exposure to surrounding healthy tissues. This precision makes proton therapy particularly beneficial for treating cancers in sensitive locations, such as near the brain, spine, and in pediatric cases. Radiation oncologists evaluate patient eligibility for proton therapy, considering its potential for improved outcomes and reduced long-term side effects.
Palliative Radiation Therapy
Palliative radiation therapy aims to relieve symptoms caused by cancer, such as pain, bleeding, or obstruction, without necessarily curing the disease. It can significantly improve the quality of life for patients with advanced cancer or those not eligible for curative treatment. Radiation oncologists work closely with patients and their families to determine the goals of palliative care, customizing treatment plans to provide symptom relief while minimizing side effects, ensuring patient comfort and dignity in managing cancer symptoms.
Pediatric Oncology specializes in diagnosing and treating children with cancer, encompassing a wide range of malignancies that occur in childhood, including leukemia, brain tumors, lymphomas, and solid tumors. This field emphasizes treatments tailored to the unique needs of children and adolescents, integrating medical care with support for emotional, developmental, and educational needs during and after treatment.
Leukemia
Leukemia, the most common cancer in children, affects the blood and bone marrow, leading to the production of abnormal blood cells. Treatment strategies include chemotherapy, targeted therapy, and bone marrow transplantation, carefully adjusted to minimize side effects and protect growing bodies. Pediatric oncologists, alongside a multidisciplinary team, provide comprehensive care, ensuring children receive the most effective, age-appropriate treatments while supporting their physical and emotional well-being through innovative therapies and supportive care designed to maintain a child’s quality of life.
Brain Tumors
Brain tumors in children vary significantly from those in adults, requiring specialized approaches to treatment that consider the developing brain. Surgical removal, when possible, is often the first step, followed by radiation therapy and/or chemotherapy, depending on the tumor type and location. Pediatric oncologists work closely with neurosurgeons and radiation oncologists to design treatments that maximize efficacy while minimizing long-term cognitive and developmental impacts, emphasizing the preservation of neurological function and quality of life for pediatric patients.
Lymphomas
Lymphomas, including Hodgkin and non-Hodgkin lymphoma, represent a diverse group of cancers affecting the lymphatic system. Treatment typically involves chemotherapy, with the addition of radiation therapy or immunotherapy in certain cases. Pediatric oncologists tailor therapy to the specific type of lymphoma, considering factors such as stage and aggressiveness, to achieve the best outcomes while focusing on reducing treatment-related toxicities and preserving the child’s growth and development, ensuring a multidisciplinary approach to care that includes supportive services for the child and family.
Solid Tumors
Solid tumors, such as neuroblastoma, Wilms tumor, and sarcomas, require a coordinated treatment approach that may include surgery, chemotherapy, and radiation therapy. Pediatric oncologists assess each tumor’s characteristics to determine the most effective treatment plan, often participating in clinical trials to access new therapies. The goal is to not only treat the cancer effectively but also to manage the side effects of treatment and support the child’s overall health, integrating rehabilitation, nutritional support, and psychological services to support recovery and long-term well-being.
Supportive Care and Survivorship
Supportive care addresses the management of treatment side effects and the enhancement of life quality for children with cancer. Survivorship programs focus on the needs of children who have completed treatment, monitoring for late effects and providing ongoing health and developmental assessments. Pediatric oncologists and a dedicated care team offer support for physical, emotional, and social challenges during and after cancer treatment, emphasizing the importance of holistic care that supports the child’s return to everyday activities and helps them thrive in survivorship.
Gynecologic Oncology concentrates on diagnosing and treating cancers of the female reproductive system, including ovarian, uterine/endometrial, cervical, vulvar, and vaginal cancers. Gynecologic oncologists are specialized surgeons who also use medical and radiation therapies to treat these cancers, providing comprehensive care tailored to the unique needs of each patient.
Ovarian Cancer
Ovarian cancer, often diagnosed at a later stage, requires a combination of surgery and chemotherapy. Early detection is challenging due to vague symptoms like bloating and abdominal discomfort. Gynecologic oncologists perform debulking surgery to remove as much of the tumor as possible, followed by chemotherapy to target any remaining cancer cells. Advances in targeted therapies and immunotherapy offer additional treatment options, improving outcomes and quality of life for patients with ovarian cancer.
Uterine/Endometrial Cancer
Uterine or endometrial cancer is characterized by abnormal growth inside the uterus. Treatment typically begins with surgery, including hysterectomy and removal of affected lymph nodes, to prevent cancer spread. Depending on the stage and grade, additional treatments such as radiation, chemotherapy, or hormone therapy may be recommended. Gynecologic oncologists assess each patient’s case to determine the most effective, personalized treatment plan, incorporating newer targeted therapies as appropriate.
Cervical Cancer
Cervical cancer treatment depends on the stage at diagnosis, with early stages often treated with surgery alone and more advanced stages requiring a combination of chemotherapy, radiation, and sometimes surgery. Vaccination against HPV, a major risk factor for cervical cancer, and regular screening through Pap smears can significantly reduce the risk. Gynecologic oncologists play a key role in managing treatment plans, which may include innovative approaches like minimally invasive surgery and targeted therapies to enhance outcomes.
Vulvar and Vaginal Cancers
Vulvar and vaginal cancers are rare and typically treated with surgery to remove the tumor, sometimes necessitating radiation or chemotherapy for more advanced disease. Gynecologic oncologists focus on preserving sexual function and minimizing impact on quality of life, employing reconstructive techniques when necessary. Personalized treatment plans are developed based on the cancer’s extent, patient’s health status, and preferences, aiming for the best possible functional and cosmetic outcomes.
Gestational Trophoblastic Disease
Gestational trophoblastic disease encompasses a range of rare tumors that develop in the cells that would normally form the placenta during pregnancy. Treatment often involves chemotherapy, with surgery reserved for specific cases. Gynecologic oncologists specialize in treating these conditions, offering expertise in monitoring hCG levels and providing treatments aimed at preserving fertility whenever possible. Early detection and treatment lead to excellent outcomes for most patients with gestational trophoblastic disease.
Hematologic Oncology focuses on the diagnosis, treatment, and management of cancers that affect the blood, bone marrow, and lymphatic system, such as leukemia, lymphoma, and myeloma. Hematologic oncologists employ a combination of therapies including chemotherapy, immunotherapy, targeted therapy, and stem cell transplantation to treat these complex diseases, aiming to achieve remission and maintain patients’ quality of life.
Leukemia
Leukemia is a type of cancer affecting the blood and bone marrow, characterized by the overproduction of abnormal white blood cells. Treatment varies by type (acute or chronic) and may include chemotherapy, targeted therapy, and stem cell transplantation. Hematologic oncologists tailor treatment plans to each patient’s specific disease and overall health, often involving a multidisciplinary team to manage the side effects of treatment and support the patient’s physical and emotional well-being throughout their care.
Lymphoma
Lymphoma, including Hodgkin and non-Hodgkin types, involves the lymphatic system and presents with symptoms such as enlarged lymph nodes, fatigue, and weight loss. Treatment strategies can range from watchful waiting in slow-growing types to aggressive chemotherapy, immunotherapy, and radiation therapy for more advanced stages. Hematologic oncologists develop individualized treatment plans based on the type and stage of lymphoma, focusing on innovative therapies that offer the potential for long-term control and remission of the disease.
Myeloma
Myeloma is a cancer of plasma cells in the bone marrow that produces abnormal antibodies, leading to bone pain, kidney dysfunction, and increased infection risk. Treatment includes chemotherapy, targeted therapy, immunotherapy, and stem cell transplantation, aiming to control the disease, relieve symptoms, and extend life. Hematologic oncologists work closely with patients to manage the complex needs associated with myeloma, providing access to the latest treatments and clinical trials to improve outcomes and quality of life.
Stem Cell Transplantation
Stem cell transplantation, including autologous (using the patient’s own cells) and allogeneic (using cells from a donor), is a treatment option for various hematologic cancers. This procedure aims to restore healthy bone marrow function after high-dose chemotherapy or radiation therapy. Hematologic oncologists, in collaboration with a specialized transplant team, carefully evaluate patients for this treatment, considering factors such as disease stage, overall health, and availability of a suitable donor, to offer the best chance for a successful outcome.
Targeted Therapy and Immunotherapy
Targeted therapy and immunotherapy represent advances in hematologic oncology, offering treatments that specifically target cancer cells or enhance the body’s immune response to cancer. These therapies can be more effective and have fewer side effects than traditional treatments. Hematologic oncologists determine the appropriateness of these therapies based on the genetic and molecular characteristics of the cancer, incorporating them into personalized treatment plans that offer new hope for patients with hematologic malignancies.
Neuro-Oncology focuses on the diagnosis and treatment of brain and spinal cord tumors, both malignant and benign. This subspecialty involves a multidisciplinary approach, combining the expertise of neuro-oncologists, neurosurgeons, radiation oncologists, and medical oncologists to provide comprehensive care. Treatments may include surgery, radiation therapy, chemotherapy, and targeted therapies, tailored to the specific type and location of the tumor and the overall health of the patient.
Brain Tumors
Brain tumors, including gliomas, meningiomas, and metastatic tumors, present unique challenges due to their critical location. Treatment strategies often begin with surgical removal to reduce tumor size and relieve symptoms, followed by radiation therapy and/or chemotherapy to target remaining cancer cells. Neuro-oncologists work closely with patients to develop personalized treatment plans that balance maximizing tumor control with preserving neurological function, utilizing advanced diagnostic imaging and molecular testing to guide therapy choices and improve outcomes.
Spinal Cord Tumors
Spinal cord tumors, which may be primary or metastatic, can cause pain, neurological deficits, and paralysis. Treatment typically involves surgery to remove or reduce the tumor, possibly followed by radiation therapy or chemotherapy, depending on the tumor type. Neuro-oncologists and neurosurgeons collaborate to plan the safest approach to surgery, aiming to alleviate symptoms and preserve spinal cord function. The choice of additional treatments is based on a thorough evaluation of the tumor’s characteristics and the patient’s overall condition.
Pediatric Brain Tumors
Pediatric brain tumors require specialized treatment approaches that consider the developing brain. Neuro-oncologists, in collaboration with pediatric oncologists, tailor treatments to minimize long-term cognitive and developmental impacts while effectively controlling the tumor. This may include less aggressive surgery, precise radiation therapy techniques, and chemotherapy protocols designed for children. Supportive care addressing the emotional and psychological needs of young patients and their families is integral to the treatment plan, ensuring a child-friendly approach to cancer care.
Targeted Therapy and Immunotherapy
Advancements in targeted therapy and immunotherapy offer new hope for patients with brain and spinal cord tumors, providing options that specifically target tumor cells with potentially fewer side effects than traditional chemotherapy. Neuro-oncologists evaluate the molecular profile of tumors to identify actionable targets and recommend appropriate targeted agents or immunotherapies. These treatments, often part of clinical trials, represent a growing area of neuro-oncology, aiming to improve survival rates and quality of life for patients with challenging diagnoses.
Palliative Care
Palliative care in neuro-oncology focuses on improving the quality of life for patients with advanced brain and spinal cord tumors, addressing pain, neurological symptoms, and psychological needs. Neuro-oncologists collaborate with palliative care specialists to provide comprehensive support, ensuring patients and their families receive care that manages symptoms effectively, facilitates clear communication about treatment goals, and supports decision-making processes that reflect the patient’s values and preferences, emphasizing comfort and dignity throughout the course of the disease.
Thoracic Oncology specializes in the diagnosis and treatment of cancers within the thoracic cavity, primarily lung cancer and cancers of the chest wall, mediastinum, and pleura. Thoracic oncologists work closely with a multidisciplinary team, including thoracic surgeons, medical oncologists, radiation oncologists, and pulmonologists, to provide comprehensive care tailored to the individual patient, integrating advanced surgical techniques, chemotherapy, radiation therapy, targeted therapy, and immunotherapy to improve outcomes.
Lung Cancer
Lung cancer, the leading cause of cancer death worldwide, includes non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatment strategies depend on the cancer’s type, stage, and the patient’s overall health, often involving a combination of surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. Thoracic oncologists utilize molecular profiling to identify actionable mutations, guiding the use of targeted therapies and immunotherapies that have significantly improved survival rates and quality of life for patients with advanced lung cancer.
Mesothelioma
Mesothelioma, a rare cancer associated with asbestos exposure, affects the lining of the lungs (pleura) and other internal organs. Treatment is challenging and may include surgery to remove the tumor and affected tissue, combined with chemotherapy and radiation therapy to control disease spread. Thoracic oncologists and mesothelioma specialists focus on multimodal approaches to extend survival and alleviate symptoms, increasingly incorporating targeted therapies and immunotherapy into treatment plans to offer hope for improved outcomes in this difficult-to-treat cancer.
Thymoma and Thymic Carcinoma
Thymoma and thymic carcinoma are rare tumors of the thymus gland, with treatment often involving surgical resection followed by adjuvant therapy based on the tumor’s aggressiveness and stage. Thoracic oncologists collaborate with thoracic surgeons to achieve optimal surgical outcomes, considering radiation therapy and chemotherapy for more advanced cases. The multidisciplinary approach ensures comprehensive care, aiming to achieve complete tumor removal and manage potential complications, such as myasthenia gravis, commonly associated with thymic tumors.
Chest Wall Tumors
Chest wall tumors, which can be benign or malignant, require careful evaluation to determine the most appropriate treatment approach, including surgery, radiation therapy, and sometimes chemotherapy. Thoracic oncologists work with thoracic surgeons to plan and perform resections that aim to completely remove the tumor while preserving chest wall function and appearance. Reconstructive techniques may be utilized to repair and rebuild the chest wall, ensuring the best possible functional and cosmetic outcomes for patients.
Pleural Diseases
Pleural diseases, including malignant pleural effusions and pleural mesothelioma, involve the pleura surrounding the lungs. Management strategies may include therapeutic thoracentesis to remove excess fluid and relieve symptoms, indwelling pleural catheters for long-term fluid management, and surgical interventions for more definitive treatment. Thoracic oncologists employ a patient-centered approach to manage pleural diseases, focusing on symptom relief, quality of life, and integrating emerging treatments like immunotherapy to target underlying malignancies more effectively.
Genitourinary Oncology focuses on cancers of the urinary system and male genital tract, including prostate, bladder, kidney, testicular, and penile cancers. This subspecialty combines medical, surgical, and sometimes radiation treatments to manage these cancers, emphasizing personalized care plans based on the type and stage of cancer, as well as the patient’s overall health and treatment preferences.
Prostate Cancer
Prostate cancer is the most common cancer among men, with treatment options ranging from active surveillance for low-risk cases to surgery, radiation therapy, hormonal therapy, chemotherapy, and advanced targeted therapies for more aggressive diseases. Genitourinary oncologists assess each patient’s cancer characteristics, considering factors like PSA levels and Gleason scores, to recommend the most appropriate treatment strategy. The goal is to effectively manage the cancer while minimizing side effects, particularly focusing on preserving urinary and sexual function.
Bladder Cancer
Bladder cancer treatment often begins with transurethral resection to remove cancerous tissue, followed by intravesical therapy, chemotherapy, or immunotherapy, depending on the stage and recurrence risk. For muscle-invasive bladder cancer, more aggressive treatments like radical cystectomy with urinary diversion may be necessary. Genitourinary oncologists work closely with patients to determine the best course of action, integrating emerging treatments like checkpoint inhibitors that offer new hope for advanced cases, aiming to balance effective cancer control with quality of life considerations.
Kidney Cancer
Treatment for kidney cancer, particularly renal cell carcinoma, may include surgery to remove part or all of the affected kidney, targeted therapy, or immunotherapy, with a move towards nephron-sparing procedures whenever possible to preserve kidney function. Genitourinary oncologists tailor treatment plans to the tumor’s size, location, and genetic makeup, utilizing advanced imaging and genetic profiling to guide therapy choices and improve outcomes, focusing on strategies that maximize the chance of cure while minimizing long-term complications.
Testicular Cancer
Testicular cancer, though rare, is highly treatable and usually curable, with a multidisciplinary approach involving surgery to remove the affected testicle, followed by chemotherapy or radiation depending on the type and stage. Genitourinary oncologists emphasize fertility preservation and the management of long-term effects, providing comprehensive care that addresses the immediate needs of treating cancer and the importance of maintaining quality of life and fertility for survivors, incorporating the latest advances in treatment to ensure the best possible outcomes.
Penile Cancer
Penile cancer requires specialized treatment to manage the disease effectively while striving to preserve penile function and appearance. Options may include laser surgery, circumcision, partial or total penectomy, and in advanced cases, chemotherapy or radiation therapy. Genitourinary oncologists and surgeons collaborate to offer treatments that achieve the best cancer control with the least impact on sexual and urinary function, supporting patients through decision-making processes and post-treatment rehabilitation, focusing on both oncologic outcomes and psychosocial well-being.
Gastrointestinal Oncology focuses on the diagnosis, treatment, and management of cancers within the gastrointestinal (GI) tract and associated organs, including the esophagus, stomach, pancreas, liver, gallbladder, bile ducts, small intestine, colon, and rectum. This subspecialty involves a multidisciplinary approach, combining the expertise of gastroenterologists, surgical oncologists, medical oncologists, radiation oncologists, and radiologists to offer comprehensive care. Treatment strategies may include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy, tailored to each patient’s specific type of cancer and its stage.
Esophageal Cancer
Esophageal cancer treatment often starts with a combination of chemotherapy and radiation therapy to shrink the tumor before surgery, aiming to remove the affected section of the esophagus. For patients with advanced disease, targeted therapies and immunotherapies may provide additional options. Gastrointestinal oncologists work closely with patients to develop treatment plans that offer the best chance for cure or control of the disease, focusing on preserving swallowing function and quality of life through innovative surgical techniques and supportive care measures.
Stomach (Gastric) Cancer
Treatment for stomach cancer may include surgery to remove the tumor and surrounding lymph nodes, along with chemotherapy and radiation therapy to eliminate any remaining cancer cells. For advanced or metastatic gastric cancer, targeted therapies and immunotherapies have emerged as effective treatments. Gastrointestinal oncologists personalize therapy based on the cancer’s characteristics and the patient’s overall health, emphasizing nutritional support and management of symptoms to maintain strength and well-being throughout the treatment process.
Pancreatic Cancer
Pancreatic cancer is one of the most challenging GI cancers to treat, often requiring surgery, chemotherapy, and sometimes radiation therapy. Due to the complexity of pancreatic tumors, treatment frequently involves novel combinations of therapies, including targeted treatments and immunotherapies for certain genetic profiles. Gastrointestinal oncologists collaborate with a multidisciplinary team to provide comprehensive care, aiming to extend survival and improve quality of life with cutting-edge research and supportive care tailored to each patient’s needs.
Colorectal Cancer
Colorectal cancer treatment typically involves surgery to remove the cancerous tissue and affected lymph nodes, possibly followed by chemotherapy and radiation therapy, depending on the cancer’s stage and location. Advances in genetic and molecular profiling have led to the use of targeted therapies and immunotherapies for colorectal cancer, offering personalized treatment options that can significantly improve outcomes. Gastrointestinal oncologists are committed to early detection through screening and prevention, as well as providing multidisciplinary care to manage the disease effectively and support patients through their treatment journey.
Liver Cancer
Liver cancer, including hepatocellular carcinoma, often requires a combination of treatments such as surgical resection, liver transplantation, ablative therapies, and transarterial chemoembolization (TACE). For advanced liver cancer, targeted therapies and immunotherapies offer new hope for treatment. Gastrointestinal oncologists assess each patient’s liver function and cancer stage to develop an individualized treatment plan, integrating the latest advances in liver cancer care to optimize outcomes and focusing on liver health and symptom management throughout the treatment process.
Oncology, a cornerstone of modern medicine, focuses on battling cancer through a multidisciplinary approach that spans prevention, diagnosis, treatment, and survivorship care. Our dedicated oncology team combines cutting-edge research with compassionate care to address the unique challenges faced by each patient.We aim ro provide patients and their families with comprehensive insights into the tests, treatments, and supportive measures integral to cancer care. By promoting understanding and collaboration, we empower patients to participate actively in their treatment decisions, ensuring a journey through cancer care that is informed, supported, and centered on the individual’s needs.
Biopsy
The biopsy, a critical diagnostic tool, involves extracting tissue samples for detailed analysis, providing definitive evidence of cancer’s presence and characteristics. It serves as a foundation for personalized treatment planning, offering insights into the cancer’s aggressiveness and potential responsiveness to treatments.
Imaging Tests
Advanced imaging technologies, such as CT, MRI, and PET scans, serve as the eyes of oncology, revealing the unseen details of cancer’s presence, size, and spread. These tools are essential for staging cancer, guiding surgical interventions, and evaluating the effectiveness of ongoing treatments, playing a pivotal role in the comprehensive management of cancer.
Blood Tests
Blood tests in oncology go beyond routine checks, searching for specific markers that could indicate the presence of cancer or provide insights into the body’s response to treatment. They are crucial for tracking the disease’s progression and tailoring treatment strategies over time.
Genetic Testing
Genetic testing offers a glimpse into the patient’s inherited risks, enabling targeted preventive measures and the selection of therapies that are more likely to be effective against genetically predisposed cancers, thus ushering in the era of precision medicine in oncology.
Endoscopy
Through endoscopy, physicians gain direct visual access to the body’s interior, spotting early signs of cancer in accessible areas. This procedure is invaluable for early detection, biopsy sampling, and sometimes even for performing minor treatments.
Liquid Biopsy
Liquid biopsy is a cutting-edge diagnostic test that detects cancer cells or their DNA fragments in blood samples. This non-invasive method offers a way to monitor tumor dynamics in real-time, assess treatment response, and detect minimal residual disease or early relapse. It represents a significant advancement in personalized cancer care, providing critical insights without the need for traditional, more invasive biopsy procedures.
Molecular Profiling
Molecular profiling analyzes cancer at the genetic level to identify unique mutations and alterations driving the disease. This comprehensive approach enables oncologists to match patients with the most effective targeted therapies or clinical trials, tailoring treatment plans to the specific molecular characteristics of their cancer. It’s a cornerstone of precision oncology, optimizing treatment outcomes and minimizing unnecessary side effects.
Surgery
Surgical oncology remains a pillar of cancer treatment, with the goal of removing tumors and, if necessary, nearby affected tissues or lymph nodes. Innovations in surgical techniques, including robotic-assisted surgeries, have refined this approach, minimizing invasiveness and enhancing patient recovery.
Chemotherapy
Chemotherapy, a mainstay in cancer treatment, employs a variety of drugs to systematically target and kill cancer cells. Its use is tailored to the individual, often forming part of a multimodal treatment plan that may include surgery and radiation, to maximize the chances of eradicating the cancer.
Radiation Therapy
Radiation therapy strategically targets tumors with precision, destroying or shrinking cancer cells while sparing surrounding healthy tissue. Technological advances have significantly improved the precision and outcomes of radiation therapy, making it a critical component of curative and palliative cancer care.
Immunotherapy
Immunotherapy represents a breakthrough in cancer care, offering hope where traditional treatments may fall short. By mobilizing the body’s immune system to recognize and attack cancer cells, immunotherapy has changed the prognosis for many patients, particularly those with types of cancer that were previously considered challenging to treat.
Targeted Therapy
Targeted therapy exemplifies personalized cancer treatment, focusing on specific molecular targets associated with cancer. This approach allows for the direct disruption of cancer’s growth and spread mechanisms, offering a potent strategy with potentially fewer side effects than traditional chemotherapy.
CAR T-Cell Therapy
Chimeric Antigen Receptor (CAR) T-cell therapy is a form of immunotherapy that genetically engineers a patient’s T-cells to better recognize and attack cancer cells. This treatment has shown remarkable success, particularly in certain types of leukemia and lymphoma that are resistant to other treatments. CAR T-cell therapy represents a paradigm shift in cancer treatment, offering potentially curative outcomes for patients with previously untreatable cancers.
Oncolytic Virus Therapy
Oncolytic virus therapy uses genetically modified viruses that selectively infect and destroy cancer cells while sparing healthy cells. Beyond their direct anticancer effects, these viruses can also stimulate an immune response against the tumor. This innovative approach is currently being explored in various cancers, with some oncolytic viruses already approved for treatment.
Tumor Treating Fields (TTF)
Tumor Treating Fields (TTF) is a non-invasive therapeutic technology that uses electric fields to disrupt cancer cell division and growth. Approved for the treatment of specific brain tumors, TTF involves wearing a device that delivers low-intensity, alternating electric fields directly to the tumor site. This method offers a novel mechanism of action against cancer, with ongoing research exploring its potential in other types of tumors.
Pain Management: Comprehensive pain management strategies, encompassing medications, nerve blocks, and integrative therapies, are tailored to address the unique pain experiences of cancer patients, aiming to improve comfort and quality of life throughout treatment and recovery.
Palliative Care: Palliative care stands as a beacon of holistic support, addressing the physical, emotional, and spiritual needs of patients and their families. This multidisciplinary approach ensures that care is aligned with the patient’s values and preferences, enhancing the quality of life even in the face of advanced disease.
Nutritional Support: Personalized nutritional counseling plays a critical role in supporting patients through the challenges of cancer treatment, helping to manage side effects, maintain strength, and promote healing. Nutritionists work closely with patients to develop diets that support their specific needs and treatment goals.
Psychological Support: Recognizing the profound emotional impact of cancer, our team provides comprehensive psychological support, including counseling and access to support groups. These services offer a safe space for patients and families to navigate the emotional challenges of cancer, fostering resilience and well-being.
Consultant, Clinical Oncology
Oncology | 31 years of experience | Speaks English, ArabicAreas of Expertise:
Registrar, Medical Oncology
Oncology | 13 years of experience | Speaks English, ArabicAreas of Expertise:
Department Head, Oncology
Oncology | 40 years of experience | Speaks English, ArabicAreas of Expertise:
Consultant, Adult Oncology
Oncology | 7 years of experience | Speaks English, ArabicAreas of Expertise:
This package offers a holistic approach to managing both Type 1 and Type 2 Diabetes, focusing on advanced diagnostics, personalized consultations, and a custom follow-up plan.
The aim is to achieve optimal blood sugar control and reduce the risk of diabetes-related complications.
The benefits include improved quality of life through comprehensive management, lowering the risk of long-term complications, and providing personalized education and care.
Blood Glucose Monitoring: Measures the current blood sugar levels to manage daily diabetes control.
A1C Testing: Provides a 2-3 month average of blood sugar levels to assess long-term glucose control.
Lipid Profile: Evaluates the risk of cardiovascular diseases by measuring cholesterol and triglycerides.
Kidney Function Tests: Checks for the health of kidneys, which can be affected by diabetes.
Thyroid Function Tests: Important as diabetes patients are more prone to thyroid disorders.
Diabetic Retinopathy Screening: Early detection of eye problems caused by diabetes, preventing vision loss.
Endocrinologist Consultations: Initial and follow-up meetings for medical management of diabetes.
Dietary Planning with a Dietician: Personalized nutrition advice to manage blood sugar and overall health.
Diabetes Education Sessions: Provides knowledge and skills for daily diabetes management.
Package Cost
AED 0.00
Book an Appointment